TITLE

COMMENTARY: Review: Quadruple therapies appear to be more effective than triple therapies for eradicating single-drug-resistant Helicobacter pylori

AUTHOR(S)
Chiba, Naoki
PUB. DATE
January 2008
SOURCE
ACP Journal Club;Jan/Feb2008, Vol. 148 Issue 1, p9
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The author comments on the study which examines the effect of antibiotic resistance status on the efficacy of triple and quadruple therapies for Helicobacter pylori. According to the author, metronidazole (MTN) resistance seems to be less important than clarithromycin (CTM) resistance because it can be overcome to some extent. With the amoxicillin-nitroimidazole-bismuth triple therapy, a larger daily close of nitroimidazole can eradicate resistant strains.
ACCESSION #
28694433

 

Related Articles

  • Limited Efficacy of Omeprazole--based Dual and Triple Therapy for Helicobacter pylori: A Randomized Trial Employing "Optimal" Dosing. Laine, Loren; Stein, Craig; Neil, Garry // American Journal of Gastroenterology;Sep1995, Vol. 90 Issue 9, p1407 

    Objectives: To evaluate the efficacy and side effects of dual omeprazole/amoxicillin therapy for Helicobacter pylori given in "optimal" fashion (omeprazole twice a day, 3 g of amoxicllin daily, drugs started concurrently, 2 wk of therapy) and to assess the utility of adding a second antibiotic,...

  • The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis. Changcheng Wang; Yuhong Yuan; Hunt, Richard H. // American Journal of Gastroenterology;Aug2007, Vol. 102 Issue 8, p1789 

    OBJECTIVE: Helicobacter pylori ( H. pylori) is recognized as a definite carcinogen for gastric cancer. The prevalence of H. pylori infection in patients with gastric cancer varies widely among studies and no meta-analysis on the prevalence of H. pylori infection in early gastric cancer (EGC) has...

  • Sequential therapy boosts H pylori eradication rates. Allmon, Amanda; Stevermer, James J.; Ewigman, Bernard // Journal of Family Practice;Oct2008, Vol. 57 Issue 10, p651 

    The article reports on the result of an analysis which examined two kinds of therapy in treating with Helicobacter pylori infection in the U.S. It reveals that in an meta-analysis used with two kinds of therapy, the researchers found a median adherence rate of 97.4% for sequential therapy....

  • Helicobacter Pylori and Migraine: Systematic Evaluation of 1084 Cases with Meta-Analysis. Mann, Nirmal S.; Singh, Sital // International Medical Journal;Apr2015, Vol. 22 Issue 2, p65 

    Objectives: Helicobacter pylori (HP) is a gram-negative organism, which can cause gastritis, peptic ulcer disease, gastric lymphoma and gastric cancer. It has also been implicated in conditions such as coronary artery disease, short stature, iron deficiency anemia, hypertension, cerebral...

  • Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis. Bao-Zhu Li; Threapleton, Diane Erin; Ji-Yao Wang; Jian-Ming Xu; Jin-Qiu Yuan; Chao Zhang; Peng Li; Qian-Ling Ye; Biao Guo; Chen Mao; Dong-Qing Ye // BMJ: British Medical Journal;8/22/2015, Vol. 351 Issue 8022, ph4052 

    The article provides information on a study on the most efficacious treatments for the eradication of Helicobacter pylori. The previously widely used standard triple treatment composed of a proton inhibitor plus clarithromycin with amoxicillin or metronidazole was said to be outperformed in...

  • The Prevalence of Helicobacter pylori Infection in the Peoples Republic of China. Li, Y. Y.; Hu, P. J.; Du, G. G.; Hazell, S. L. // American Journal of Gastroenterology;Apr1991, Vol. 86 Issue 4, p446 

    Meta-analysis on data from 16 (two volunteer and 14 endoscopic) studies has been performed to investigate the prevalence of Helicobacter pylori infection in the stomachs of individuals within the Peoples Republic of China. In this survey covering 2216 cases (89 volunteers and 2127 endoscopy...

  • Treatment of Helicobacter pylori Infection with Omeprazole-- Amoxicillin Combination Therapy versus Ranitidine/Sodium Bicarbonate--Amoxicillin. Al-Assi, Mohammad T.; Cole, Rhonda A. // American Journal of Gastroenterology;Sep1995, Vol. 90 Issue 9, p1411 

    Objectives: Simpler, effective therapies to treat Helicobacter pylori infection are greatly needed. Omeprazole co-therapy apparently enhances effectiveness of some antimicrobials. Our objective in this study was to determine whether the apparent additional benefit provided by omeprazole to...

  • Levofloxacin-Based First-Line Therapy versus Standard First-Line Therapy for Helicobacter pylori Eradication: Meta-Analysis of Randomized Controlled Trials. Peedikayil, Musthafa Chalikandy; AlSohaibani, Fahad Ibrahim; Alkhenizan, Abdullah Hamad // PLoS ONE;Jan2014, Vol. 9 Issue 1, p1 

    Background: First-line levofloxacin-based treatments eradicate Helicobacter pylori with varying success. We examined the efficacy and safety of first-line levofloxacin-based treatment in comparison to standard first-line therapy for H pylori eradication. Materials and Methods: We searched...

  • Selecting the Optimum First‑line Treatment for H. pylori Eradication. Ang, Tiing L.; Almadi, Majid A. // Saudi Journal of Gastroenterology;Jul/Aug2015, Vol. 21 Issue 4, p183 

    The authors reflect on the study of Alsohaibani and colleagues that compared triple therapy with sequential therapy for the treatment of Helicobacter pylori eradication in Saudi Arabia. The authors commented on the use of adequate acid suppression aimed to prevent the inactivation of antibiotics...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics